Solara Active Pharma Sciences Ltd

NSE: SOLARA · BSE: 541540 · Pharmaceuticals & Biotechnology · 36 announcements

Share price: ₹668.45
Market cap: ₹3,220 Cr
Revenue (annual): ₹1,369 Cr
Net profit (annual): ₹-7.41 Cr
P/E (TTM): 87.2×Sector 43.8×
Promoter holding: 41.93%+0.00% QoQ
FII holding: 10.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Other Announcement 1 Financial Results 1 Employee Stock Options 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

16 Oct 2026 19:22 IST NSE

Earnings Call

Solara Active Pharma Sciences Earnings Call Transcript: Key Takeaways

Solara delivered its best profitability in five years despite ongoing Ibuprofen pricing and raw material challenges.

Open call summary → Read the filing ↗

16 Oct 2026 13:48 IST NSE

Earnings Call

Solara Active Pharma Sciences Investor Presentation: Key Takeaways

Solara's Q2 FY27 delivered record EBITDA and PAT in five years, driven by 33% revenue growth. Base business strength offset Ibuprofen headwinds, which is now nearing breakeven.

Open call summary → Read the filing ↗